Condition: Painful Diabetic Neuropathy (PDN) · Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation) · Type 1 Diabetes Mellitus (T1DM) · Sponsor: Chulalongkorn University
Painful diabetic neuropathy (PDN) is one of the most common and disabling complications of diabetes mellitus, substantially affecting quality of life, daily functioning, and health system burden. Early identification of PDN is crucial for timely treatment, prevention of complications such as foot ulcers and amputations, and for reducing healthcare costs. However, in Thailand there are limited culturally adapted and validated tools for screening PDN. PainPREDICT is an internationally validated questionnaire designed to characterize neuropathic pain profiles, but its adaptation for Thai patients has not yet been undertaken. In parallel, the use of mobile health technologies (mHealth) has the potential to expand access to screening and monitoring of chronic conditions, particularly in resource-limited settings.
This description comes directly from the study's public registry record.
Jakkrit Amornvit, MD · +66622169338 · jakkrit.a@chula.ac.th
Tharadon Deepracha, MSc · +66622169338 · tharadon.d@chulahospital.org
Always discuss trial participation with your own doctor first.
| King Chulalongkorn Memorial hospital, The Thai Red Cross Society | Pathum Wan, Bangkok, Thailand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07195045